UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047811
Receipt number R000054505
Scientific Title Continuous intake test in summer 2022
Date of disclosure of the study information 2022/07/04
Last modified on 2022/05/20 09:30:22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Continuous intake test in summer 2022

Acronym

Continuous intake test in summer 2022

Scientific Title

Continuous intake test in summer 2022

Scientific Title:Acronym

Continuous intake test in summer 2022

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Efficacy of test foods

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Blood components, skin color, and awareness of sensitive skin and skin condition before and after ingestion of test foods for 8 weeks

Key secondary outcomes

Skin measurements, image data, biological components (stratum layer, sebum, flora, SSL-RNA) before and after ingestion of test foods for 4 and 8 weeks


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Consume test foods twice a day for 8 consecutive weeks

Interventions/Control_2

Consume placebo foods twice a day for 8 consecutive weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

49 years-old >=

Gender

Female

Key inclusion criteria

-Healthy females
-Sensitive skin conscious person

Key exclusion criteria

-Subjects have abnormalities on the skin of the test site (face, inside forearm)
-Subjects who attend medical institutions at all times
-Subjects who use the drug at all times
-Subjects with severe atopic dermatitis or hay fever
-Subjects have received cosmetic medicine
-Subjects judged by the person in charge of the examination to be inappropriate

Target sample size

44


Research contact person

Name of lead principal investigator

1st name Kaori
Middle name
Last name Tojo

Organization

Kao Corporation

Division name

Skin Care Products Research Laboratory

Zip code

1318501

Address

2-1-3, Bunka, Sumida-ku, Tokyo, Japan 1318501

TEL

+81-3-5630-9557

Email

tojo.kaori@kao.com


Public contact

Name of contact person

1st name Noriko
Middle name
Last name Haketa

Organization

Kao Corporation

Division name

Skin Care Products Research Laboratory

Zip code

1318501

Address

2-1-3, Bunka, Sumida-ku, Tokyo, Japan 1318501

TEL

+81-3-5630-7286

Homepage URL


Email

haketa.noriko@kao.com


Sponsor or person

Institute

Kao Corporation

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Human Research Ethics Committee, Kao Corporation

Address

2-1-3 Bunka, Sumida-ku, Tokyo 131-8501, JAPAN

Tel

+81-3-5630-7263

Email

morisaki.naoko@kao.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

株式会社インフォワード(東京都)


Other administrative information

Date of disclosure of the study information

2022 Year 07 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2022 Year 04 Month 15 Day

Date of IRB

2022 Year 04 Month 15 Day

Anticipated trial start date

2022 Year 07 Month 04 Day

Last follow-up date

2022 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 05 Month 20 Day

Last modified on

2022 Year 05 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054505


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name